No shortage on file

ORENCIA

BRISTOL-MYERS SQUIBB CANADA

Quick answers

Is there a shortage of ORENCIA in Canada?

No. There is no current shortage of ORENCIA 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file1 product

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

ORENCIA

BRISTOL-MYERS SQUIBB CANADA

125MG · DIN 02402475

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

DIN

02282097

Strength

250MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

ABATACEPT

See all ABATACEPT products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-06-16

Resolved

Disruption of the manufacture of the drug.

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ABRAXANE FOR INJECTABLE SUSPENSION

100MG · DIN 02281066

BARACLUDE

0.5MG · DIN 02282224

BREYANZI

120000000CELLS · DIN 02527138

CAMZYOS

15MG · DIN 02532573

CAMZYOS

5MG · DIN 02532557

CAMZYOS

2.5MG · DIN 02532549